| ACN | Acetonitrile |
| AML | Acute Myeloid Leukaemia |
| APEX | Absolute Protein Expression (semi-quantitative index) |
| BET | Bromodomain and Extra-Terminal domain |
| cCRE | Candidate Cis-Regulatory Element |
| Co-IP-MS | Co-Immunoprecipitation Mass Spectrometry |
| CUT&Tag | Cleavage Under Targets and Tagmentation |
| DEG | Differentially Expressed Gene |
| DMSO | Dimethyl Sulfoxide |
| EPO | Erythropoietin |
| eRNA | Enhancer RNA |
| FACS | Fluorescence-Activated Cell Sorting |
| FBS | Foetal Bovine Serum |
| FC | Fold Change |
| FDR | False Discovery Rate |
| GEO | Gene Expression Omnibus |
| HSPCs | Haematopoietic Stem and Progenitor Cells |
| HAT | Histone Acetyltransferase |
| HCS | High-Content Screening |
| LSC | Leukaemic Stem Cell |
| MDS | Myelodysplastic Syndrome |
| PCA | Principal Component Analysis |
| PDX | Patient-Derived Xenograft |
| PPI | Protein–Protein Interaction |
| RNAP2 | Polymerase II RNA |
| RPKM | Reads Per Kilobase per Million mapped reads |
| TES | Transcription End Site |
| Ti-IMAC | Titanium-Immobilised Metal Affinity Chromatography |
| TMT | Tandem Mass Tag |
| TSS | Transcription Start Site |